Announcements Trials

Browse Landscape

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cyclophosphamide 58 Rituximab 54 fludarabine 33 fludarabine phosphate 32 venetoclax 24 Filgrastim 22 Etoposide 18 Bendamustine Hydrochloride 18 Gemcitabine 17 Peripheral Blood Stem Cell Transplantation 15 Bortezomib 15 Melphalan 14 obinutuzumab 13 Lenalidomide 12 Dexamethasone 12 Cytarabine 12 Vincristine 11 Vorinostat 10 Tacrolimus 10 Azacitidine 10 pembrolizumab 9 Prednisone 9 Mycophenolic Acid 9 Doxorubicin 9 ibrutinib 8 copanlisib 8 Whole-Body Irradiation 8 Radiotherapy 8 Paclitaxel 8 Interleukin-2 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, Non-Hodgkin × lucatumumab × Clear all

NCT01275209 2020-12-08

LIFT

Novartis

Phase 1 Completed

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡